Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma

Clinical trial NCT07411144 · COMPLETED

Trial details

NCT number: NCT07411144
Sponsor: National Cancer Institute, Egypt
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Pleural Mesothelioma (DPM)

Start date: 2020-03-15
Primary completion: 2023-03-15
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.